A case of erythrodermic psoriasis in which adalimumab injection sites are preserved

Dermatol Ther. 2021 Mar;34(2):e14865. doi: 10.1111/dth.14865. Epub 2021 Feb 18.

Authors

Ilknur Ozcan¹, Ayse Serap Karadag², Eylem Ceren³, Busra Demirci¹, Filiz Cebeci¹

Affiliations

¹ Department of Dermatology, Istanbul Medeniyet University School of Medicine Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.
² Department of Dermatology, Memorial Atasehir Hospital, Istanbul, Turkey.
³ Department of Dermatology, Health Science University, Fatih Sultan Mehmet Hospital, Istanbul, Turkey.

PMID: 33569858
DOI: 10.1111/dth.14865

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / adverse effects
Adalimumab / therapeutic use
Dermatitis, Exfoliative* / chemically induced
Dermatitis, Exfoliative* / diagnosis
Humans
Psoriasis* / diagnosis
Psoriasis* / drug therapy

Substances

Adalimumab